Edmond H. Fischer

Edmond H. Fischer was a Swiss-American biochemist who made a fundamental discovery in the field of cellular regulation. He shared the Nobel Prize in Physiology or Medicine in 1992 with his collaborator Edwin G. Krebs for their work describing reversible protein phosphorylation. Their research revealed a critical biochemical switch that governs countless processes in eukaryotic cells, from metabolism to gene expression.

Early life and education

Born in the International Settlement of Shanghai to Austrian parents, Fischer was educated in Switzerland after the outbreak of World War II. He initially pursued studies in microbiology and chemistry at the University of Geneva, where he earned his doctorate in 1947 under the supervision of Kurt H. Meyer. His early research focused on the enzyme alpha-amylase, laying the groundwork for his future investigations into enzyme regulation. Following his PhD, he conducted postdoctoral work in the United States before returning to the University of Geneva.

Career and research

In 1953, Fischer joined the faculty of the University of Washington in Seattle, where he began his historic collaboration with Edwin G. Krebs. Their work was initially inspired by studies of glycogen metabolism, particularly the activation of the enzyme phosphorylase. They discovered that the interconversion between active and inactive forms of phosphorylase was controlled by the addition and removal of phosphate groups, a process mediated by opposing enzymes: a protein kinase and a protein phosphatase. This mechanism, termed reversible protein phosphorylation, was soon recognized as a universal regulatory system. Their laboratories at the University of Washington School of Medicine became world-renowned centers for the study of signal transduction and cell signaling.

Nobel Prize in Physiology or Medicine

Fischer and Krebs were jointly awarded the Nobel Prize in Physiology or Medicine in 1992 for their discovery of "reversible protein phosphorylation as a biological regulatory mechanism." The Nobel Assembly at the Karolinska Institutet highlighted that their work provided a central explanation for how hormones and other extracellular signals control complex activities inside the cell. The prize underscored the profound impact of their finding on understanding diseases like cancer, diabetes, and neurodegenerative disease, where phosphorylation pathways are often disrupted. The award ceremony in Stockholm celebrated a partnership that fundamentally reshaped modern molecular biology.

Later work and legacy

Following the Nobel Prize, Fischer remained an active researcher and emeritus professor at the University of Washington, investigating the roles of phosphorylation in systems such as the cytoskeleton and cell division. He was a passionate advocate for basic scientific research and served on numerous advisory boards, including for the National Institutes of Health and the Howard Hughes Medical Institute. His legacy is cemented by the thousands of scientists who continue to explore the phosphoproteome, and his discovery remains a cornerstone of drug discovery efforts targeting kinases and phosphatases in numerous pathologies.

Awards and honors

In addition to the Nobel Prize, Fischer received many prestigious recognitions. He was elected a member of the United States National Academy of Sciences and a foreign member of the Royal Society (ForMemRS). His other honors included the Albert Lasker Award for Basic Medical Research, the Passano Award, and the Wolf Prize in Medicine. He held honorary doctorates from several institutions, including the University of Basel and the University of Geneva. The conference room of the Department of Biochemistry at the University of Washington is named in his and Krebs's honor.

Category:American biochemists Category:Nobel laureates in Physiology or Medicine Category:University of Washington faculty Category:Wolf Prize in Medicine laureates